Not applicableStudy completedNCT04560790
What this trial is testing
Safety and Efficacy of CRISPR/Cas9 mRNA Instantaneous Gene Editing Therapy to Treat Refractory Viral Keratitis
Who this might be right for
Viral KeratitisBlindness EyeHerpes Simplex Virus Infection+1 more
Shanghai BDgene Co., Ltd. 3